Skip to content
TrialScanner

NCT03687242

Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia

Phase 2CompletedSPRBLead

Registry record

Lead sponsor
Spruce Biosciences
Conditions
Congenital Adrenal Hyperplasia; CAH - Congenital Adrenal Hyperplasia; CAH - 21-Hydroxylase Deficiency
Primary completion
Jul 8, 2019Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03687242 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03687242: Study to Evaluate the Safety... | TrialScanner